Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy


Condition: Prostate Cancer (Post Prostatectomy), Prostate Cancer (Adenocarcinoma), Prostate Cancer (Diagnosis), Prostate Specific Antigen, Radical Prostatectomy

Study Type: Observational [Patient Registry]

Clinical Trials Identifier NCT 8-digits: NCT07516886

Sponsor: Lithuanian University of Health Sciences

Phase:

Eligibility:

  • Age: minimum 18 Years maximum N/A
  • Gender: Male

Inclusion Criteria:

  • Patient is an adult biological male.
  • Patient has morphologically confirmed and untreated prostate cancer.
  • Patient who will be treated with open, laparoscopic or robot-assisted laparoscopic radical prostatectomy.
  • Patient is informed about this observational study and has signed the informed consent form.

Exclusion Criteria:

  • Patient has radiologically of morphologically confirmed prostate cancer metastases before the operation.
  • Patient received neoadjuvant prostate cancer treatment.
  • Patient is set to receive adjuvant treatment.
  • Patient has any contraindications for the operation.

View trial on ClinicalTrials.gov